Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Denisa Muraru
Discover the details of the session
This session organized by EACVI Club 35 was devoted to the most recent evidence on prognostic stratification using cardiac imaging modalities.
Dr. Shkolnik (Russia) adressed the prognostic markers in heart failure, as well as the discrepancy between guidelines and every day practice. A very promising prognostic marker is global 2D longitudinal strain (GLS) for either left or right ventricular function. However, simpler parameters (ejection fraction (EF), tricuspid annular plane systolic excursion (TAPSE), left atrial volume index etc) still represent the mainstay for predicting outcome in heart failure patients.
Dr.Mimoun (France) presented novel prognostic markers in asymptomatic patients with severe aortic stenosis, such as global longitudinal strain, exercise-induced changes in mean gradient or myocardial fibrosis on cardiac magnetic resonance imaging. The prognosis of patients with paradoxical low-flow low-gradient severe aortic stenosis remains controversial. For asymptomatic organic mitral regurgitation, left atrial size, contractile reserve and exercise-induced changes in pulmonary pressure and regurgitation, severity can be used for risk stratification.
Dr. Cesana (Italy) discussed automated carotid intima-media thickness measurements or pulsed-wave velocity as prognostic indices in preclinical atherosclerosis. Multiple non-invasive markers could reliably predict the presence of significant coronary artery disease.
Dr. Gonçalves (Portugal) underlined the value of cardiac magnetic resonance imaging and global longitudinal strain for assessing myocardial fibrosis burden as a predictor of events in patients with hypertrophic cardiomyopathy (HCM). Myocardial crypts could be a novel cardiac magnetic resonance imaging marker, encountered in genotype +/phenotype – HCM patients. “Apical sparing” on 2D longitudinal strain analysis appears to be a highly specific marker for differentiating cardiac amyloidosis from other causes of LV hypertrophy, while its preservation in basal segments may help in the diagnosis of non-compaction cardiomyopathy.
Although uncertainties persist and there is much work still to be done, there is a growing recognition of the ability of non-invasive imaging modalities to improve outcome prediction.
The best in 2012: Imaging and outcome (club 35)
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 BIOT
06903Sophia Antipolis, FR
© 2017 European Society of Cardiology. All rights reserved